help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nambi, P.
Right arrow Articles by Edwards, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nambi, P.
Right arrow Articles by Edwards, R. M.

Endocrinology, Vol 131, 1081-1086, Copyright © 1992 by Endocrine Society

ARTICLES

Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands

P Nambi, M Pullen, HL Wu, N Aiyar, EH Ohlstein and RM Edwards
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.

High affinity and high density endothelin (ET)-binding sites were identified in membranes prepared from human kidney cortex and medulla. Saturation binding experiments performed in membranes prepared from cortex and medulla using [125I]ET-1 and [125I]ET-3 revealed that the proportion of [125I]ET-3-binding sites was 30-35% less than that of [125I]ET-1-binding sites. The apparent dissociation constants and maximum binding for [125I]ET-1 and [125I]ET-3 to membranes from cortex were 91 +/- 5 pM and 165 +/- 10 fmol/mg protein, and 117 +/- 9 pM and 110 +/- 7 fmol/mg protein, respectively, whereas in medulla they were 139 +/- 10 pM and 360 +/- 11 fmol/mg protein, and 142 +/- 11 pM and 245 +/- 15 fmol/mg protein, respectively. In the presence of 10 nM sarafotoxin-6c, which is selective for ETB receptors, [125I]ET-1 binding was decreased by 65-70%, whereas [125I]ET-3 binding was totally abolished, suggesting that 65-70% of [125I]ET-1 binding and 100% of [125I]ET-3 binding was to ETB receptors. This was further confirmed by the use of a cyclic pentapeptide [cyclo(D-Trp,D-Asp,L-Pro, D-Val,L- Leu)] (BQ123), which is selective for ETA receptors. In the presence of 1 microM BQ123, [125I]ET-1 binding was decreased by 25-30%, whereas [125I]ET-3 binding was unaffected, confirming that 30-35% of ET receptors belong to the ETA subtypes, and that [125I]ET-1 bound to both ETA and ETB receptors with the same high affinity, but [125I]ET-3 bound only to ETB receptors with high affinity. These results suggest that human kidney cortex and medulla contain ETA and ETB receptors in a ratio of 30:70, and that sarafotoxin-6c and BQ123 are valuable tools in identifying the subtype of ET receptors in various tissues.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
E. H. Bae, K. S. Lee, J. Lee, S. K. Ma, N. H. Kim, K. C. Choi, J. Frokiaer, S. Nielsen, S. Y. Kim, S. Z. Kim, et al.
Effects of {alpha}-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F272 - F280.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. L. Tycho Vuurmans, P. Boer, and H. A. Koomans
Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2742 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Endothelin
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301.
[Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. M. POLLOCK
Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1
Physiol Genomics, June 6, 2001; 6(1): 39 - 43.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Yamashita, M. Itoh, T. Kuro, Y. Kobayashi, M. Ogata, M. Takaoka, and Y. Matsumura
Pre- or Post-Ischemic Treatment with a Novel Na+/Ca2+ Exchange Inhibitor, KB-R7943, Shows Renal Protective Effects in Rats with Ischemic Acute Renal Failure
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 412 - 419.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T.-J. Hsieh, S.-R. Lin, Y.-J. Lee, S.-J. Shin, Y.-H. Lai, C.-H. Hsu, and J.-H. Tsai
Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats
Am J Physiol Renal Physiol, July 1, 2000; 279(1): F112 - F121.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Hoffman, Z. A. Abassi, S. Brodsky, R. Ramadan, and J. Winaver
Mechanisms of Big Endothelin-1-Induced Diuresis and Natriuresis : Role of ETB Receptors
Hypertension, March 1, 2000; 35(3): 732 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Pupilli, P. Romagnani, L. Lasagni, F. Bellini, N. Misciglia, N. Emoto, M. Yanagisawa, M. Rizzo, M. Mannelli, and M. Serio
Localization of endothelin-converting enzyme-1 in human kidney
Am J Physiol Renal Physiol, November 1, 1997; 273(5): F749 - F756.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Holm and A. Franco-Cereceda
TISSUE CONCENTRATIONS OF ENDOTHELINS AND FUNCTIONAL EFFECTS OF ENDOTHELIN-RECEPTOR ACTIVATION IN HUMAN ARTERIES AND VEINS
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 264 - 272.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society